68208-46-8Relevant articles and documents
18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography
Hu, Feng,Morris, Patrick J.,Bonaventura, Jordi,Fan, Hong,Mathews, William B.,Holt, Daniel P.,Lam, Sherry,Boehm, Matthew,Dannals, Robert F.,Pomper, Martin G.,Michaelides, Michael,Horti, Andrew G.
, (2021)
Designer Receptors Exclusively Activated by Designer Drugs (DREADD) are a preclinical chemogenetic approach with clinical potential for various disorders. In vivo visualization of DREADDs has been achieved with positron emission tomography (PET) using su